Cargando…

Cellular distribution of monoclonal antibody in human tumours after i.v. administration.

Immune-suppressed mice carrying xenografts of several different types of human germ-cell tumours were injected with a radiolabelled monoclonal antibody (LICR LON/HT13) raised against membrane components of a human germ-cell tumour (HX39). Subsequent assessment of radioactivity in excised organs and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moshakis, V., McIlhinney, R. A., Neville, A. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1981
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010824/ https://www.ncbi.nlm.nih.gov/pubmed/6172141

Ejemplares similares

Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies.
por: Moshakis, V., et al.
Publicado: (1981)

The site of binding of anti-CEA antibodies to tumour CEA in vivo: an immunocytochemical and autoradiographic approach.
por: Moshakis, V., et al.
Publicado: (1982)

Tumour and cellular localization by use of monoclonal and polyclonal antibodies to placental alkaline phosphatase.
por: Jeppsson, A., et al.
Publicado: (1984)

Localization of human breast-carcinoma xenografts using antibodies to carcinoembryonic antigen.
por: Moshakis, V., et al.
Publicado: (1981)

Structural basis for cell surface patterning through NetrinG–NGL interactions
por: Seiradake, Elena, et al.
Publicado: (2011)

Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.
por: Otsuji, E., et al.
Publicado: (1996)

Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.
por: Moseley, R. P., et al.
Publicado: (1990)

Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After US Food and Drug Administration Deauthorization
por: Anderson, Timothy S., et al.
Publicado: (2022)

Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
por: Follmann, Dean, et al.
Publicado: (2023)

Is routine replacement of i.v. administration sets required after each change of intermittently administrated antibiotic infusions?
por: von Au, Felix, et al.
Publicado: (2013)

Molecular and cellular basis for immunomodulation with monoclonal antibodies
por: Melero, Ignacio
Publicado: (2015)

Proceedings of an international workshop on monoclonal antibodies to tumour antigens.
Publicado: (1981)

Monoclonal antibody‐mediated killing of tumour cells by neutrophils
por: Heemskerk, Niels, et al.
Publicado: (2018)

Monoclonal antibodies against chicken type IV and V collagens: electron microscopic mapping of the epitopes after rotary shadowing
Publicado: (1984)

Administration of Monoclonal Antibody for COVID-19 in Patient Homes
por: Malani, Anurag N., et al.
Publicado: (2021)

Pregnancy outcomes after administration of monoclonal antibody therapy for COVID-19
por: Martinez-Baladejo, Maria T., et al.
Publicado: (2023)

The diffusion of a tumour-specific monoclonal antibody in lymphoma infiltrated spleen.
por: Cobb, L. M., et al.
Publicado: (1987)

Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
por: Desrues, B., et al.
Publicado: (1995)

Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody.
por: Rathjen, D. A., et al.
Publicado: (1992)

Tumour localisation with a radioactively labelled reshaped human monoclonal antibody.
por: Hird, V., et al.
Publicado: (1991)

On the monoclonality of tumours.
por: Baverstock, K. F.
Publicado: (1986)

Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in the Mouse Eye Following Systemic Administration
por: Bussing, David, et al.
Publicado: (2021)

Development of a novel bi-specific monoclonal antibody approach for tumour targeting
por: Koumarianou, A A, et al.
Publicado: (1999)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.
por: Dorreen, M. S., et al.
Publicado: (1982)

Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
por: Walter, Sarah, et al.
Publicado: (2014)

Monoclonal antibody assay of serum placental alkaline phosphatase in the monitoring of testicular tumours.
por: Epenetos, A. A., et al.
Publicado: (1985)

Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model.
por: Rowlinson-Busza, G., et al.
Publicado: (1995)

Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
por: Durrant, L. G., et al.
Publicado: (1989)

I.V. Stalin : esbozo biográfico.
Publicado: (1940)

Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies Associated With Administration of Afucosylated Humanized Monoclonal Antibodies
por: Adedeji, Adeyemi O., et al.
Publicado: (2022)

1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection
por: Vikraman, Praveen Kumar, et al.
Publicado: (2022)

Antibody-dependent cellular cytotoxicity to human colon-tumour cells. I. Lack of tumour specificity in a population study
por: Shoham, J., et al.
Publicado: (1979)

Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits.
por: Ledermann, J. A., et al.
Publicado: (1988)

T10B9 monoclonal antibody: A short-acting nonstimulating monoclonal antibody that spares γδ T-cells and treats and prevents cellular rejection
por: Waid, Thomas H, et al.
Publicado: (2009)

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.
por: Modjtahedi, H., et al.
Publicado: (1996)

Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.
por: Edwards, P. A.
Publicado: (1985)

Heparin, dextran 1000 and metastasis formation after I.V. tumour cell injection in dextran non-sensitive rats.
por: Ivarsson, L., et al.
Publicado: (1975)

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
por: Halwe, Sandro, et al.
Publicado: (2021)

Preparation, Characterization, Pharmacokinetics and Biodistribution of Baicalin-Loaded Liposome on Cerebral Ischemia-Reperfusion after i.v. Administration in Rats
por: Li, Nan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mlntra1u6cumpkddj7hh65tmfu